Home › NDC Lookup › RxCUI directory › RxCUI 403914

Methscopolamine bromide 5 MG Oral Tablet — RxCUI 403914

RxNorm drug concept · Semantic clinical drug
RxCUI 403914 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI403914
Official nameMethscopolamine bromide 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped11
Reported Medicaid activity (SDUD)70 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Methscopolamine bromide 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methscopolamine bromide 5 MG Oral Tablet RxCUI 403914

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Methscopolamine 89785
    • Methscopolamine bromide 56092
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pamine 219055
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methscopolamine Oral Tablet 372845
    • Methscopolamine bromide Oral Tablet 2647479
    • Methscopolamine Oral Product 1162861
    • Methscopolamine Pill 1162862
    • Methscopolamine bromide Oral Product 2662704
    • Methscopolamine bromide Pill 2659743
    • Methscopolamine Oral Tablet [Pamine] 368178
    • Methscopolamine bromide Oral Tablet [Pamine] 2655549
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Methscopolamine bromide 5 MG 1861557
    • Methscopolamine bromide 5 MG Oral Tablet [Pamine] 404640
    • Methscopolamine bromide 5 MG [Pamine] 1861559

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methscopolamine bromide 5 MG SCDC · 1861557
  • Methscopolamine Oral Tablet SCDF · 372845
  • Methscopolamine bromide Oral Tablet SCDFP · 2647479
  • Methscopolamine Oral Product SCDG · 1162861
  • Methscopolamine Pill SCDG · 1162862
  • Methscopolamine bromide Oral Product SCDGP · 2662704
  • Methscopolamine bromide Pill SCDGP · 2659743

Brand-Name Concepts

  • Methscopolamine bromide 5 MG Oral Tablet [Pamine] SBD · 404640
  • Methscopolamine bromide 5 MG [Pamine] SBDC · 1861559
  • Methscopolamine Oral Tablet [Pamine] SBDF · 368178
  • Methscopolamine bromide Oral Tablet [Pamine] SBDFP · 2655549
  • Pamine Oral Product SBDG · 1179442
  • Pamine Pill SBDG · 1179443
  • Pamine BN · 219055

📦 FDA Products & Package NDCs

8 products · 11 package NDCs
11 package NDCs map to RxCUI 403914 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43063-0741-60 60 TABLET in 1 BOTTLE, PLASTIC (43063-741-60) METHSCOPOLAMINE BROMIDE PD-Rx Pharmaceuticals, Inc. 2017-02-01
51991-0191-01 100 TABLET in 1 BOTTLE (51991-191-01) Methscopolamine Bromide Breckenridge Pharmaceutical, Inc. 2012-05-21
51991-0192-06 60 TABLET in 1 BOTTLE (51991-192-06) Methscopolamine Bromide Breckenridge Pharmaceutical, Inc. 2012-05-21
51991-0192-60 5 BLISTER PACK in 1 BOX (51991-192-60) / 12 TABLET in 1 BLI... Methscopolamine Bromide Breckenridge Pharmaceutical, Inc. 2012-05-21
72162-2472-06 60 TABLET in 1 BOTTLE (72162-2472-6) METHSCOPOLAMINE BROMIDE Bryant Ranch Prepack 2026-03-13
72319-0029-04 100 TABLET in 1 BOTTLE (72319-029-04) METHSCOPOLAMINE BROMIDE i3 Pharmaceuticals, LLC 2024-12-18
72319-0029-06 1000 TABLET in 1 BOTTLE (72319-029-06) METHSCOPOLAMINE BROMIDE i3 Pharmaceuticals, LLC 2024-12-18
72319-0030-02 60 TABLET in 1 BOTTLE (72319-030-02) METHSCOPOLAMINE BROMIDE i3 Pharmaceuticals, LLC 2024-12-18
72319-0030-06 1000 TABLET in 1 BOTTLE (72319-030-06) METHSCOPOLAMINE BROMIDE i3 Pharmaceuticals, LLC 2024-12-18
76385-0100-01 100 TABLET in 1 BOTTLE (76385-100-01) METHSCOPOLAMINE BROMIDE Unichem Pharmaceuticals (USA), Inc. 2013-10-01
76385-0101-60 60 TABLET in 1 BOTTLE (76385-101-60) METHSCOPOLAMINE BROMIDE Unichem Pharmaceuticals (USA), Inc. 2013-10-01
Observed labelers: i3 Pharmaceuticals, LLC (4) · Breckenridge Pharmaceutical, Inc. (3) · Unichem Pharmaceuticals (USA), Inc. (2) · Bryant Ranch Prepack (1) · PD-Rx Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.